Skip to main content

Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Seattle Genetics, Inc

Start Date

September 1, 2020

End Date

November 30, 2025
 

Administered By

Duke Cancer Institute

Awarded By

Seattle Genetics, Inc

Start Date

September 1, 2020

End Date

November 30, 2025